Continued donepezil treatment is effective for Alzheimer's disease

03/8/2012 | PhysiciansBriefing.com

A U.K. study involving 295 patients with moderate to severe Alzheimer's disease found that those who continued taking donepezil experienced significant cognitive and functional benefits compared with patients who stopped taking donepezil after three months. The findings appeared in The New England Journal of Medicine.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC